Emerald Mutual Fund Advisers Trust Sarepta Therapeutics, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.45 Billion
- Q4 2024
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 19,100 shares of SRPT stock, worth $2.02 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
19,100
Previous 1,018
1776.23%
Holding current value
$2.02 Million
Previous $127,000
1728.35%
% of portfolio
0.16%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.09 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$959 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$918 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$457 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$430 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.24B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...